218 related articles for article (PubMed ID: 23494230)
1. Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.
Cunningham CS; McMahon LR
Psychopharmacology (Berl); 2013 Jul; 228(2):321-33. PubMed ID: 23494230
[TBL] [Abstract][Full Text] [Related]
2. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
Cunningham CS; McMahon LR
Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys.
Cunningham CS; Javors MA; McMahon LR
J Pharmacol Exp Ther; 2012 Jun; 341(3):840-9. PubMed ID: 22438471
[TBL] [Abstract][Full Text] [Related]
4. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
de Moura FB; McMahon LR
Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
[TBL] [Abstract][Full Text] [Related]
5. Patterns of nicotinic receptor antagonism: nicotine discrimination studies.
Jutkiewicz EM; Brooks EA; Kynaston AD; Rice KC; Woods JH
J Pharmacol Exp Ther; 2011 Oct; 339(1):194-202. PubMed ID: 21730011
[TBL] [Abstract][Full Text] [Related]
6. Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.
LeSage MG; Shelley D; Ross JT; Carroll FI; Corrigall WA
Pharmacol Biochem Behav; 2009 Jan; 91(3):461-7. PubMed ID: 18817808
[TBL] [Abstract][Full Text] [Related]
7. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
Ortiz NC; O'Neill HC; Marks MJ; Grady SR
Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
[TBL] [Abstract][Full Text] [Related]
8. The discriminative stimulus effects of i.v. nicotine in rhesus monkeys: Pharmacokinetics and apparent pA
Moerke MJ; Zhu AZ; Tyndale RF; Javors MA; McMahon LR
Neuropharmacology; 2017 Apr; 116():9-17. PubMed ID: 27940077
[TBL] [Abstract][Full Text] [Related]
9. Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats.
Sotomayor-Zárate R; Gysling K; Busto UE; Cassels BK; Tampier L; Quintanilla ME
Psychopharmacology (Berl); 2013 May; 227(2):287-98. PubMed ID: 23344555
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus and hypothermic effects of some derivatives of the nAChR agonist epibatidine in mice.
Rodriguez JS; Cunningham CS; Moura FB; Ondachi P; Carroll FI; McMahon LR
Psychopharmacology (Berl); 2014 Dec; 231(23):4455-66. PubMed ID: 24800895
[TBL] [Abstract][Full Text] [Related]
11. Unexpected loss of sensitivity to the nicotinic acetylcholine receptor antagonist activity of mecamylamine and dihydro-β-erythroidine in nicotine-tolerant mice.
de Moura FB; Wilkerson JL; McMahon LR
Brain Behav; 2020 Apr; 10(4):e01581. PubMed ID: 32092237
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.
Peng C; Stokes C; Mineur YS; Picciotto MR; Tian C; Eibl C; Tomassoli I; Guendisch D; Papke RL
J Pharmacol Exp Ther; 2013 Nov; 347(2):424-37. PubMed ID: 23959137
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.
Rollema H; Shrikhande A; Ward KM; Tingley FD; Coe JW; O'Neill BT; Tseng E; Wang EQ; Mather RJ; Hurst RS; Williams KE; de Vries M; Cremers T; Bertrand S; Bertrand D
Br J Pharmacol; 2010 May; 160(2):334-45. PubMed ID: 20331614
[TBL] [Abstract][Full Text] [Related]
14. Differential cross-tolerance to the effects of nicotinic acetylcholine receptor drugs in C57BL/6J mice following chronic varenicline.
de Moura FB; McMahon LR
Behav Pharmacol; 2019 Aug; 30(5):412-421. PubMed ID: 30398980
[TBL] [Abstract][Full Text] [Related]
15. Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats.
Igari M; Alexander JC; Ji Y; Qi X; Papke RL; Bruijnzeel AW
Neuropsychopharmacology; 2014 Jan; 39(2):455-65. PubMed ID: 23966067
[TBL] [Abstract][Full Text] [Related]
16. Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats.
Biala G; Staniak N; Budzynska B
Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr; 381(4):361-70. PubMed ID: 20217050
[TBL] [Abstract][Full Text] [Related]
17. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
18. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
19. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
20. Differential antagonism and tolerance/cross-tolerance among nicotinic acetylcholine receptor agonists: scheduled-controlled responding and hypothermia in C57BL/6J mice.
de Moura FB; McMahon LR
Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):240-8. PubMed ID: 26910582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
